Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP26A1 | O43174 | 2/20 | 0.39 |
| ▸ | CYP26B1 | Q9NR63 | 1/20 | 0.39 |
| ▸ | RARA | P10276 | 5/20 | 0.38 |
| ▸ | RARB | P10826 | 5/20 | 0.38 |
| ▸ | RARG | P13631 | 5/20 | 0.38 |
| ▸ | PTGER4 | P35408 | 13/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CRABP2 | P29373 | 1/20 | 0.36 |
| ▸ | RXRA | P19793 | 2/20 | 0.35 |
| ▸ | HNF4A | P41235 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9302931 | 0.89 | RARA (0.39) | CYP26A1CYP26B1RARARARBRARG | |
| SCHEMBL9301914 | 0.88 | PTGER4 (0.35) | PTGER4 | |
| SCHEMBL9304352 | 0.88 | CYP26A1 (0.46) | CYP26A1CYP26B1RARARARBRARG | |
| SCHEMBL9303121 | 0.86 | RXRA (0.34) | CYP26A1CYP26B1RARARARBRARG | |
| SCHEMBL9301731 | 0.85 | CYP26A1 (0.41) | CYP26A1CYP26B1RARARARBRARG | |
| SCHEMBL9304108 | 0.84 | RARA (0.39) | CYP26A1CYP26B1RARARARBRARG | |
| SCHEMBL9301902 | 0.81 | CYP3A4 (0.53) | CYP26A1CYP26B1RARARARBRARG | |
| SCHEMBL9303176 | 0.80 | RARB (0.41) | CYP26A1CYP26B1RARARARBRARG | |
| SCHEMBL9302106 | 0.78 | CYP3A4 (0.33) | RARARARBRARGCYP3A4 | |
| SCHEMBL9301689 | 0.77 | RXRA (0.35) | RARARARBRARGCYP3A4RXRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5354752-A | A dimethylthiochroman or dimethylchroman-6-yl-ethynyl-pyridazin- or pyrimidin- or pyrazin-for treating skin disorders psoriasis | ALLERGAN, INC. (US) | 1994-10-11 | — | — | US | claimed |